Prosecution Insights
Last updated: November 20, 2026
Application No. 19/672,017

SYSTEMS FOR ANALYZING THE EYE

Non-Final OA §102§DOUBLEPATENT
Filed
May 08, 2026
Priority
Nov 07, 2023 — provisional 63/547,628 +3 more
Examiner
HASAN, MOHAMMED A
Art Unit
2872
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Lightfield Medical Inc.
OA Round
2 (Non-Final)
90%
Grant Probability
Favorable
2-3
OA Rounds
1y 4m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 90% — above average
90%
Career Allowance Rate
1628 granted / 1802 resolved
+22.3% vs TC avg
Moderate +5% lift
Without
With
+5.2%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 10m
Avg Prosecution
21 currently pending
Career history
1833
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
59.1%
+19.1% vs TC avg
§102
31.2%
-8.8% vs TC avg
§112
4.9%
-35.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1802 resolved cases

Office Action

§102 §DOUBLEPATENT
DETAILED ACTION Information Disclosure Statement The prior art documents submitted by application in the Information Disclosure Statement filed on 10/5/2026 and 10/28/2026 and 10/12/2026 have all been considered and made of record ( note the attached copy of form PTO – 1449). Double Patenting 2. The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 13-16 are rejected on the ground of nonstatutory obviousness -type double patenting as being unpatentable over claims 1-5 respectively U.S.Patent No. 12,440,102 B2. Although the conflicting claims are not identical they are not patentable distinct from each other because the instant claims are anticipated by the patented claims. The claims of the instant application corresponds to the patented claim as follows: Analysis the claims at issue are not identical, they are not patentably distinct from each other because they are but different definitions of the same disclosed subject matter, varying in breadth or scope of definition as set forth in MPEP 806.03. In this case, claims 1-5 of Patent 12,440,102 B2 include all structural elements as now claimed. An observation system the illumination system and the observation system being positioned in a first spatial configuration with an optical axis of the first adjustable optical assembly and an optical axis of the second optical assembly intersecting at an apex of a cornea of the eye. Instant Application 19/672,017 Regarding claim 13, A medical device for imaging at least a portion of an eye of a patient, the medical device comprising:an illumination system including a digital projector producing at least one image to illuminate the eye and a first adjustable optical assembly to project the at least one image towards the eye;an observation system including a second adjustable optical assembly positioned to receive imaging rays produced by reflection of light from the eye of the patient due to the projection of the at least one image towards the eye by the illumination system and a first camera configured receive the imaging rays from the second adjustable optical assembly, the illumination system and the observation system being positioned in a first spatial configuration relative to the eye; and a controller operatively coupled to the illumination system and to the observation system, the controller configured to align the illumination system and the observation system to the eye and configured to adjust the first adjustable optical assembly of the illumination system and the second adjustable optical assembly of the observation system to a plurality of focal depths relative to the eye while the illumination system and observation system are in the first spatial configuration. Regarding claim 14, The medical device of claim 13, wherein the at least one image includes a test pattern. Regarding claim 15, The medical device of claim 14, wherein the test pattern includes a vertical slit and in a first image of the at least one image the vertical slit is in a first transverse position and in a second image of the at least one image the vertical slit is in a second transverse position, the second traverse position in the second image of the at least one image being spaced apart from the first transverse position in the first image. Regarding claim 16, The medical device of claim 15, wherein the controller focuses the first adjustable optical assembly of the illumination system at a first focal depth of the plurality of focal depths when the first image of the at least one image is produced by the digital projector to focus the vertical slit in the first transverse position on a cornea of the eye at a first location offset from an apex of the cornea of the eye and focuses the first adjustable optical assembly of the illumination system at a second focal depth of the plurality of focal depths when the second image of the at least one image is produced by the digital projector to focus the vertical slit in the second transverse position on the cornea of the eye at a second location offset from the apex of the cornea of the eye, the second location on the cornea of the eye being offset from the first location on the cornea of the eye and wherein the controller further focuses the second adjustable optical assembly of the observation system at the first focal depth of the plurality of focal depths when the first image of the at least one image is produced by the digital projector to focus the vertical slit in the first transverse position on the cornea of the eye at the first location offset from the apex of the cornea of the eye and focuses the second adjustable optical assembly of the observation system at the second focal depth of the plurality of focal depths when the second image of the at least one image is produced by the digital projector to focus the vertical slit in the second transverse position on the cornea of the eye at the second location offset from the apex of the cornea of the eye. U.S.Patent No. 12,440,102B2 Regarding claim 1, A medical device for imaging at least a portion of an eye of a patient, the medical device comprising: an illumination system including a digital projector producing at least one image to illuminate the eye and a first adjustable optical assembly to project the at least one image towards the eye; an observation system including a second adjustable optical assembly positioned to receive imaging rays produced by reflection of light from the eye of the patient due to the projection of the at least one image towards the eye by the illumination system and a first camera configured receive the imaging rays from the second adjustable optical assembly, the illumination system and the observation system being positioned in a first spatial configuration with an optical axis of the first adjustable optical assembly and an optical axis of the second optical assembly intersecting at an apex of a cornea of the eye; and a controller operatively coupled to the illumination system and to the observation system, the controller configured to adjust the first adjustable optical assembly of the illumination system and the second adjustable optical system of the observation system to a plurality of focal depths relative to the eye while the illumination system and observation system are in the first spatial configuration. Regarding claim 2, The medical device of claim 1, wherein the at least one image includes a test pattern. Regarding claim 3, The medical device of claim 2, wherein the test pattern includes a vertical slit and in a first image of the at least one image the vertical slit is in a first transverse position and in a second image of the at least one image the vertical slit is in a second transverse position, the second traverse position in second image of the at least one image being spaced apart from the first transverse position in the first image. Regarding claim 4, The medical device of claim 3, wherein the controller focuses the first adjustable optical assembly of the illumination system at a first focal depth of the plurality of focal depths when the first image of the at least one image is produced by the digital projector to focus the vertical slit in the first transverse position on the cornea at a first location offset from the apex of the cornea and focuses the first adjustable optical assembly of the illumination system at a second focal depth of the plurality of focal depths when the second image of the at least one image is produced by the digital projector to focus the vertical slit in the second transverse position on the cornea at a second location offset from the apex of the cornea, the second location on the cornea being offset from the first location on the cornea. Regarding claim 5, The medical device of claim 4, wherein the controller further focuses the second adjustable optical assembly of the observation system at the first focal depth of the plurality of focal depths when the first image of the at least one image is produced by the digital projector to focus the vertical slit in the first transverse position on the cornea at the first location offset from the apex of the cornea and focuses the second adjustable optical assembly of the observation system at the second focal depth of the plurality of focal depths when the second image of the at least one image is produced by the digital projector to focus the vertical slit in the second transverse position on the cornea at the second location offset from the apex of the cornea. Allowable Subject Matter 3. Claims 1-12 are allowed. 3. The following is an examiner’s statement of reasons for allowance: The prior art taken either singularly or in a combination fails to anticipate or fairly suggest the limitations of the independent claims, in such a manner that rejection under 35 U.S.C. 102 or 103 would be proper. The prior art fails to teach a combination of all the claimed features as presented in independent claims 1 ,which include, a medical device for imaging at least a portion of an eye of a patient, the medical device having an illumination system configured to project a test pattern on the eye of the patient and a first camera positioned to capture a first image of a first portion of a reflection of the test pattern from the eye along a first direction and a second camera positioned to capture a second image of a second portion of the reflection of the test pattern from the eye along a second direction; and a display to configured to display at the same time at least a first display portion of the test pattern based on the first image and a second display portion of the test pattern based on the second image to provide an indication of an alignment state of the first camera and the second camera relative to the eye of the patient . Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Claims 17-20 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: wherein the controller is configured to adjust the first adjustable optical assembly of the illumination system and the second adjustable optical assembly of the eye while the illumination system and observation system are in the first spatial configuration, wherein a first subset of the plurality of focal depths are part of a first contour and a second subset of the plurality of focal depths are part of a second contour, the second contour being offset relative to the first contour, and wherein the digital projector produces the first image having the vertical slit in the first transverse position for a first focal depth of the first subset of the plurality of focal depths of the first contour and a first focal depth of the second subset of the plurality of focal depths of the second contour and the digital projector produces the second image having the vertical slit in the second transverse position for a second focal depth of the first subset of the plurality of focal depths and a second focal depth of second subset of the plurality of focal depths, wherein the first contour has a first shape and the second contour has a second shape, the second shape being different than the first shape and wherein the second shape is flatter than the first shape and wherein the first adjustable optical assembly of the illumination system includes a first tunable lens and the second adjustable optical assembly of the observation system includes a second tunable lens and wherein the test pattern has a first color value in a first image of the at least one image and a second color value in a second image of the at least one image, the second color value being different from the first color. Conclusion 4. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MOHAMMED A HASAN whose telephone number is (571)272-2331. The examiner can normally be reached M-TH 6 AM -4 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bumsuk Won can be reached at 571-272-2713. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MOHAMMED A HASAN/Primary Examiner, Art Unit 2872 11/8/2026
Read full office action

Prosecution Timeline

May 08, 2026
Application Filed
Jul 15, 2026
Response after Non-Final Action
Jul 30, 2026
Non-Final Rejection mailed — §102, §DOUBLEPATENT
Oct 28, 2026
Response Filed
Nov 13, 2026
Non-Final Rejection mailed — §102, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12800835
OPTICAL FIBER ARRAY COLLIMATOR APPLIED TO MULTI-LINE LiDAR
3y 10m to grant Granted Nov 17, 2026
Patent 12800939
HEAD-MOUNTED DISPLAY
2y 9m to grant Granted Nov 17, 2026
Patent 12796910
OPTOMETER FOR HOME USE
2y 5m to grant Granted Nov 17, 2026
Patent 12800934
OPTICAL DEVICE FOR AUGMENTED REALITY USING POLARIZING OPTICAL ELEMENT
2y 3m to grant Granted Nov 17, 2026
Patent 12791429
OBJECTIVE LENS ARRANGEMENT, MEASURING DEVICE AND METHOD FOR MEASURING OF A NEAR EYE DISPLAY
2y 5m to grant Granted Nov 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
90%
Grant Probability
96%
With Interview (+5.2%)
1y 10m (~1y 4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1802 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month